DLC-1 induces mitochondrial apoptosis and epithelial mesenchymal transition arrest in nasopharyngeal carcinoma by targeting EGFR/Akt/NF-κB pathway
- 17 March 2015
- journal article
- Published by Springer Nature in Medical Oncology
- Vol. 32 (4) , 1-7
Abstract
Loss of deleted in liver cancer-1 (DLC-1) can induce apoptosis and inhibit the mobility, migration and metastasis in several cancers. Previously, we revealed that ectopic expression of DLC-1 can suppress proliferation, mobility, migration and tumorigenesis in nasopharyngeal carcinoma (NPC). However, the molecular mechanisms accounting for the roles of DLC-1 in NPC are still obscure. In the present work, we attempted to study and uncover the mechanisms underlying the functions of DLC-1 in NPC. The apoptosis of 5-8F-DLC-1 cells, established previously, was analyzed by mitochondrial membrane potentials assay and flow cytometer analysis. And the antibodies involving pathways such as mitochondrial-associated apoptosis, epithelial mesenchymal transition and metastasis were applied to detect and compare the expression level of targeted proteins. The obvious apoptosis of 5-8F-DLC-1 cells was observed reflected by mitochondrial depolarization and lower ratio in cell viability. Subsequently, the activation of mitochondrial apoptosis was verified by the increased expressions of Bax, Apaf1, cleave-caspases and cleave-PARP, etc, and the decreased expressions of Bcl-2, Bcl-xL, Mcl-1, Survivin, etc, in 5-8F-DLC-1 cells. Then, the inhibited epithelial mesenchymal transition of 5-8F-DLC-1 cells was validated by upregulated expression of E-cadherin and downregulated expression of N-cadherin, Snail, Vimentin. Subsequently, downregulated expressions of proteins such as FAK, RhoA, ROCK1 and cdc25 related to cell adhesion and cytoskeleton organization were also observed. And expressions of MMPs were inhibited in 5-8F-DLC-1 cells. At last, the inhibited activity of EGFR/Akt/NF-κB axis was revealed by the decreased expressions of phosho-EGFR, phosho-Akt, phosho-p38MAPK, phosho-IKKα and phosho-p65. Here, we systematically explored the mechanisms underlying the negative roles of DLC-1 in NPC cells. For the first time, we confirmed that the ectopic expression DLC-1 can induce mitochondrial apoptosis, inhibit EMT and related processes by targeting the EGFR/Akt/NF-κB pathway, which, beyond all doubt, offered beneficial guidelines for other studies and laid a good foundation for its clinical applications ultimately.Keywords
This publication has 42 references indexed in Scilit:
- FAK signaling in human cancer as a target for therapeuticsPharmacology & Therapeutics, 2015
- Clinical significance of epithelial‐mesenchymal transitionClinical and Translational Medicine, 2014
- The EMT Universe: Space between Cancer Cell Dissemination and Metastasis InitiationCritical Reviews™ in Oncogenesis, 2014
- Cell and Molecular Biology of Epidermal Growth Factor Receptor2014
- The ErbB/HER family of protein-tyrosine kinases and cancerPharmacological Research, 2014
- Epithelial–mesenchymal plasticity in carcinoma metastasisGenes & Development, 2013
- Tensin1 Requires Protein Phosphatase-1α in Addition to RhoGAP DLC-1 to Control Cell Polarization, Migration, and InvasionJournal of Biological Chemistry, 2009
- DLC‐1:a Rho GTPase‐activating protein and tumour suppressorJournal of Cellular and Molecular Medicine, 2007
- Matrix metalloproteinases and tumor metastasisCancer and Metastasis Reviews, 2006
- Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells.Journal of Cell Biology, 1982